Stoke Therapeutics, Inc. · NASDAQ:STOK
Ticho Barry sold 4,767 Stoke Therapeutics, Inc. shares (Form 4)
Traded Aug 14 to Aug 18, 2026 · Filed Aug 18, 2026
From Aug 14 to Aug 18, 2026, Ticho Barry (CHIEF MEDICAL OFFICER) sold 4,767 Stoke Therapeutics, Inc. shares at an average US$32.03 for US$153K, leaving 25,655 shares. Filed Aug 18, 2026 (Form 4).
- Sold
- 4,767 shares
- Price
- US$32.03 average (US$32.01 to US$32.47)
- Value
- US$153K
- Holding after
- 25,655 shares
- Trading plan
- No
- Role
- CHIEF MEDICAL OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | Common Stock | Option exercise | 10,000 | 30,422 | Direct | |
| Aug 18, 2026 | Common Stock | Sale | 4,525 | US$32.01 | 25,897 | Direct |
| Aug 18, 2026 | Common Stock | Sale | 242 | US$32.47 | 25,655 | Direct |
Source
Related
- Stoke Therapeutics, Inc.
- Ticho Barry
- Stoke Therapeutics, Inc. shareholders
- Form 4 · Ticho Barry · Oct 2, 2026
- Form 4 · Ticho Barry · Sep 3, 2026
- Form 4 · Ticho Barry · Aug 5, 2026
- Form 4 · Ticho Barry · Jul 6, 2026
- Form 4 · Ticho Barry · Jun 3, 2026
- Form 4 · Allan Jonathan · Oct 2, 2026
- Schedule 13G · Biotechnology Value Fund L P · Sep 30, 2026
- Form 4 · Kaye Edward M. MD · Aug 18, 2026
- Form 4 · Allan Jonathan · Aug 18, 2026
- Schedule 13G/A · Lynx1 Capital Management LP · Aug 14, 2026